A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Clinical trial NCT06780150 · RECRUITING
Trial details
- NCT number
- NCT06780150
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-26
- Primary completion
- 2028-03-31
- Enrollment
- 842
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.